Found: 13
Select item for more details and to access through your institution.
Consistency of Extended-Release Niacin/ Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Consistency of Extended-Release Niacin/ Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups.
- Published in:
- American Journal of Cardiovascular Drugs, 2012, v. 12, n. 3, p. 197, doi. 10.2165/11631530-000000000-00000
- By:
- Publication type:
- Article
Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma-bearing C57BL/6 mice.
- Published in:
- International Journal of Cancer, 2000, v. 87, n. 1, p. 101, doi. 10.1002/1097-0215(20000701)87:1<101::AID-IJC15>3.0.CO;2-B
- By:
- Publication type:
- Article
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 1, p. 18, doi. 10.1002/clc.4960260105
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- Vascular Health & Risk Management, 2015, v. 11, p. 165, doi. 10.2147/VHRM.S70907
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 4, p. 579, doi. 10.1002/(SICI)1097-0215(19980518)76:4<579::AID-IJC22>3.0.CO;2-1
- By:
- Publication type:
- Article
Cyclophosphamide plus tumor necrosis factor-α chemoimmunotherapy cured mice: Life-long immunity and rejection of re-implanted primary lymphoma.
- Published in:
- International Journal of Cancer, 1995, v. 63, n. 3, p. 463, doi. 10.1002/ijc.2910630327
- By:
- Publication type:
- Article
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 11, p. 509, doi. 10.1002/clc.4960261106
- By:
- Publication type:
- Article
Efficacy and Safety of Ezetimibe/Simvastatin Versus Simvastatin Monotherapy in Hypercholesterolemic Patients with Metabolic Syndrome.
- Published in:
- Metabolic Syndrome & Related Disorders, 2007, v. 5, n. 1, p. 13, doi. 10.1089/met.2006.0033
- By:
- Publication type:
- Article
Polymyxin B-Mediated Lysis of Tumor Cells.
- Published in:
- International Archives of Allergy & Immunology, 1993, v. 100, n. 1, p. 47, doi. 10.1159/000236386
- By:
- Publication type:
- Article
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
- Published in:
- Lipids in Health & Disease, 2016, v. 15, p. 1, doi. 10.1186/s12944-016-0282-8
- By:
- Publication type:
- Article
Flushing Profile of Extended-Release Niacin/Laropiprant at Initiation of Therapy in Asian Lipid Clinic Patients.
- Published in:
- Cardiology, 2009, v. 114, n. 3, p. 192, doi. 10.1159/000228585
- By:
- Publication type:
- Article